/
/
/

Samrat Pharmachem Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)231.00
Volume (₹)13.00
High (₹)231.00
Upper Circuit243.05
Low (₹)228.55
Lower Circuit219.95
Prev Close231.50
52W High (₹)333.00
Price228.55
52W Low (₹)190.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)71.53 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.14
Price to Book1.35
Book Value232.39
EPS (TTM)-7.15
Face Value10.00
ROE (%)10.40

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
CIPLA-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
SAMRATPH-XNSE
LTP
1W Low
1W High
Market cap (₹)
1889.8-43.2 (-2.23%)
1882.85
1934
4,55,634Cr
9270+38 (0.41%)
9100
9288
2,41,576Cr
4887.9-116.5 (-2.33%)
4822.25
5048.55
1,84,478Cr
1382-31.15 (-2.20%)
1375.85
1415
1,11,888Cr
1157+5.8 (0.50%)
1110.55
1162.50
1,11,820Cr
1867.05+4.05 (0.22%)
1826.95
1875
99,418Cr
2107.9-44.7 (-2.08%)
2100
2170
96,529Cr
1153.4-7.6 (-0.65%)
1142.55
1165.75
96,322Cr
2313.25-66.75 (-2.80%)
2305.10
2381
96,180Cr
1651.8-4.5 (-0.27%)
1623.05
1666.60
95,127Cr
228.55+0.5 (0.22%)
226.20
239
72Cr

Key Highlights of Samrat Pharmachem Ltd Balance Sheet

Samrat Pharmachem Ltd balance sheet discloses shareholders' funds of ₹3.09Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹3.09Cr, and the reserves and surplus of the company is ₹68.71Cr.

The company has its non-current liabilities with total liabilities of ₹121.49Cr as of 2025-03-31.

The current liabilities are ₹49.58Cr as of 2025-03-31. At the same time, current assets are ₹103.36Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹3.44Cr and tangible assets of ₹10.48Cr, provided in the Samrat Pharmachem Ltd financial statements.